Author： Wang Zhijun Fan Jeffery Liu Mandy Yeung Steven Chang Andy Chow Moses SS Pon Doreen Huang Ying
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.12, 2013-12, pp. : 1613-1626
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dutasteride chemoprevention worth it for prostate cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
Access to resources
Recommend
Recent Approaches in Chemoprevention of Prostate Cancer
Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. :
Application of Pharmacogenomics to Dietary Cancer Chemoprevention
Current Pharmacogenomics, Vol. 5, Iss. 3, 2007-09 ,pp. :
Prostate cancer: dutasteride a good bet for chemoprevention . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. :
Prostate cancer chemoprevention: value rises with risk
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 606, 2010-01 ,pp. :